EICHOR
● Not Yet Recruiting
STEAM-MAP 1 Study - Steam Therapy With MRI and AI-assisted Planning
Condition: Benign Prostatic Hyperplasia (BPH) · Sponsor: Chinese University of Hong Kong
About this study
The STEAM-MAP 1 Study is a single-arm, prospective feasibility trial evaluating the integration of MRI-transrectal ultrasound (TRUS) fusion guidance into Rezūm water vapor thermal therapy for men with symptomatic benign prostatic hyperplasia (BPH).
This description comes directly from the study's public registry record.
Talk to the study team
Qinyang Alex Liu, MBBS, MSc, FRCSEd · 852+35052625 · alexliu@surgery.cuhk.edu.hk
Hong Tim Lau, MSc · 852+35053933 · timlau@surgery.cuhk.edu.hk
Always discuss trial participation with your own doctor first.
Locations (3)
| Prince of Wales Hospital | Shatin, Hong Kong | — |
| North District Hospital | Sheung Shui, Hong Kong | — |
| Alice Ho Miu Ling Nethersole Hospital | Tai Po, Hong Kong | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07663344